Astrid Manuel to Multiple Sclerosis
This is a "connection" page, showing publications Astrid Manuel has written about Multiple Sclerosis.
Connection Strength
2.683
-
Montelukast as a repurposable additive drug for standard-efficacy multiple sclerosis treatment: Emulating clinical trials with retrospective administrative health claims data. Mult Scler. 2024 May; 30(6):696-706.
Score: 0.721
-
A gene regulatory network approach harmonizes genetic and epigenetic signals and reveals repurposable drug candidates for multiple sclerosis. Hum Mol Genet. 2023 03 06; 32(6):998-1009.
Score: 0.666
-
An integrative study of genetic variants with brain tissue expression identifies viral etiology and potential drug targets of multiple sclerosis. Mol Cell Neurosci. 2021 09; 115:103656.
Score: 0.595
-
Dense module searching for gene networks associated with multiple sclerosis. BMC Med Genomics. 2020 04 03; 13(Suppl 5):48.
Score: 0.544
-
Prioritization of risk genes in multiple sclerosis by a refined Bayesian framework followed by tissue-specificity and cell type feature assessment. BMC Genomics. 2022 May 11; 23(Suppl 4):362.
Score: 0.157